Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes-Reference-Cited by-同舟云学术

Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes

Published:2018-12-15 Issue:12 Volume:9 Page:252-257
ISSN:1948-9358
Container-title:World Journal of Diabetes
language:
Short-container-title:WJD

Author:

Stapff Manfred Paul

Publisher

Baishideng Publishing Group Inc.

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference18 articles.

1. Centers for Disease Control and Prevention. National Diabetes Statistics Report. 2017. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017 Available from: URL: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf

2. The bacteriome at the onset of type 1 diabetes: A study from four geographically distant African and Asian countries

3. Digesting New Developments in Biosensors

4. Is the Mortality Benefit With Empagliflozin in Type 2 Diabetes Mellitus Too Good To Be True?

5. Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores;Cancers;2024-04-05

2. All‐cause mortality and cardiovascular outcomes with sodium‐glucose Co‐transporter 2 inhibitors, glucagon‐like peptide‐1 receptor agonists and with combination therapy in people with type 2 diabetes;Diabetes, Obesity and Metabolism;2023-06-29

3. The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review;Expert Review of Endocrinology & Metabolism;2023-05-08

4. Sex differences in guideline-directed medical therapy in 2021–22 among patients with peripheral artery disease;Vascular Medicine;2023-02-27

5. Patterns and Patients’ Characteristics Associated With Use of Sodium-Glucose Cotransporter-2 Inhibitors Among Adults With Type 2 Diabetes: A Population-based Cohort Study;Canadian Journal of Diabetes;2023-02